Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Making the News

 

Mediclinic’s Middle East problems

Insiders at Arab Health were talking about Mediclinic’s Middle East problems several weeks before the announcement which saw the shares fall 5%. So what are they saying?

Medanta targets teaching and secondary cities

Privately owned hospital group Medanta has announced it will open a multi-speciality 1,000-bed facility in the city of Bhubaneswar in Eastern India within three years, at a cost of between Rs 750 crore and Rs 1,000 crore ($113m to $150m). We speak to Dr Naresh Trehan, the group's founder and managing director to find out more about his business plan to target “under served” areas of the country, and open educational facilities which private hospitals were previously not allowed to have.

Healthcare largest segment for Air Liquide in Europe

Global industrial gas company Air Liquide saw its healthcare segment grow by 11.2% to €3.1bn globally in 2016. Healthcare is now its largest business in Europe surpassing industrial gas for the first time.

MD Medical Group expands across Russia

MD Medical Group, the Russian hospital chain rooted in Moscow with the treatment of women and children at its core, is planning to expand substantially. Healthcare Europa caught up with CEO Dr Mark Kurtser at the London Stock Exchange during part of his charm offensive, ahead of an early morning briefing to investors. Shares in MD Medical have doubled in value since June 2016, to £10.65 - so what is Kurtser doing right, and what is he planning next?

Attendo steady but outsourcing drops

With nearly 10% operating margin, Sweden’s largest elderly care services provider Attendo reports a good 2016 performance and sees its shareholders’ dividends more than double. But the results also highlight challenges in the outsourcing market and the group reports poor organic growth.

Orpea rises and Korian falls on sales figures

Combining over 145,000 beds across Europe, France’s two largest elderly care providers Korian and Orpea have released their 2016 revenue ahead of their full results later in March. But investors’ and analysts’ reactions couldn’t be more different, as Orpea’s share price soars and Korian’s tumbles.

Find Us